Corporate News

Grant of Options

05 August 2024

CNSL, (AIM:CNSL) the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 05 August 2024 the Board granted share options (the "Options") over its ordinary shares of 4.0 pence each ("Ordinary Shares") to James Cooper, Chief Operating Officer and Executive Director.

Following this grant of Options, the Company has options in issue over 20,184,049 Ordinary Shares, representing approximately 8% per cent. of the Company's total issued share capital.

Director	Number of Options granted on 05 August 2024	Exercise Price	Total options held post issue
James Cooper	2,000,000	4.0p	2,000,000

Grant of Options

The Company has granted the Options to incentivise executive director performance for the benefit of all Shareholders.

The Options are subject to time conditions (as set out below); good/bad leaver provisions; and being a director of the Company on the date of vesting.

Vesting criteria for Options are subject to time conditions as follows:

Amount Vesting	Time Condition
34 per cent. ("Tranche One")	On the first anniversary of 5 August 2024
33 per cent. ("Tranche Two")	On the second anniversary of 5 August 2024
33 per cent. ("Tranche Three")	On the third anniversary of 5 August 2024

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

For further information, please contact:

Cambridge Nutritional Sciences Plc

Jag Grewal, Chief Executive Officer

www.cnsplc.com

[email protected]

Cavendish Capital Markets Limited

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)

Nigel Birks / Harriet Ward (ECM)

Tel: 020 7220 0500

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Cooper

2.

Reason for the notification

a)

Position/status

Chief Operating Officer, Executive Director

b)

Initial notification/
Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Nutritional Sciences plc

b)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the
financial instrument

Options over Ordinary Shares of 4.0p each

Identification code

ISIN: GB00B1VCP282

b)

Nature of
the transaction

Grant of Options

c)

Price(s) and volume(s)